RFK Jr.'s hand-picked committee approves manufacture of peptides he uses
An FDA committee has voted to remove manufacturing restrictions on several peptides following pressure from HHS Secretary Robert F. Kennedy Jr. Critics note the decision was made despite a lack of clinical safety or efficacy data.
Why it matters
The move highlights potential regulatory shifts in health policy under the current administration, raising concerns about the prioritization of political influence over scientific evidence.
Stacked deck RFK Jr.’s hand-picked committee approves manufacture of peptides he uses There’s no human safety or efficacy data, but that no longer seems to matter.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in